The store will not work correctly when cookies are disabled.
1-(4-(bis(4-chlorophenyl)methyl)piperazin-1-yl)-3-nitroprop-2-en-1-one
ID: ALA4764852
PubChem CID: 145865988
Max Phase: Preclinical
Molecular Formula: C20H19Cl2N3O3
Molecular Weight: 420.30
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(/C=C/[N+](=O)[O-])N1CCN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1
Standard InChI: InChI=1S/C20H19Cl2N3O3/c21-17-5-1-15(2-6-17)20(16-3-7-18(22)8-4-16)24-13-11-23(12-14-24)19(26)9-10-25(27)28/h1-10,20H,11-14H2/b10-9+
Standard InChI Key: BGRNCERJDJHCSW-MDZDMXLPSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
28.7678 -3.8930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3533 -3.1779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3533 -4.6080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7697 -2.4652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3558 -1.7507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5299 -1.7501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1196 -2.4702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5318 -3.1819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5292 -4.6052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1188 -5.3195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5293 -6.0355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3586 -6.0328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7693 -5.3181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1185 -1.0356 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
27.1198 -6.7469 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
29.5929 -3.8930 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.0034 -4.6080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0034 -3.1779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8284 -3.1779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2429 -3.8930 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.0679 -3.8930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8284 -4.6080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4784 -3.1779 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.4784 -4.6080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2992 -4.6101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7079 -5.3220 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5314 -5.3272 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.2982 -6.0350 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
2 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 2 1 0
3 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 3 1 0
6 14 1 0
11 15 1 0
1 16 1 0
16 17 1 0
16 18 1 0
18 19 1 0
17 22 1 0
19 20 1 0
20 21 1 0
20 22 1 0
21 23 2 0
21 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
26 28 1 0
M CHG 2 26 1 28 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 420.30 | Molecular Weight (Monoisotopic): 419.0803 | AlogP: 4.02 | #Rotatable Bonds: 5 |
Polar Surface Area: 66.69 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.62 | CX LogP: 4.16 | CX LogD: 4.16 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.42 | Np Likeness Score: -0.94 |
References
1. Eaton JK,Furst L,Cai LL,Viswanathan VS,Schreiber SL. (2020) Structure-activity relationships of GPX4 inhibitor warheads., 30 (23.0): [PMID:32920142] [10.1016/j.bmcl.2020.127538] |